Stefan Blech
Impact in
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
-
- Chemical Reactions and Isotopes 2
-
- Pharmaceutical studies and practices 2
- Co-authors
- Eva Ludwig-Schwellinger (2 shared papers)Joachim Stangier (1 shared paper)Thomas Ebner (1 shared paper)Willy Roth (1 shared paper)Klaus F. Wagner (1 shared paper)Graeme C. Young (4 shared papers)Hanno Schieferstein (3 shared papers)John Smeraglia (1 shared paper)
- Journals
- Drug Metabolism and Disposition (3 papers)Clinical Pharmacology & Therapeutics (2 papers)Frontiers in Molecular Biosciences (1 paper)Bioanalysis (1 paper)International Journal for Ion Mobility Spectrometry (1 paper)
- Partner nations
- GermanyUnited KingdomBelgium
In The Last Decade
Stefan Blech
8 papers receiving 780 citations
Stefan Blech's Hit Papers
Peers
Comparison fields: 5 of 68
- Internal Medicine 248
- Cardiology and Cardiovascular Medicine 419
- Endocrinology, Diabetes and Metabolism 160
- Pharmacology 82
- Hematology 59
Countries citing papers authored by Stefan Blech
This map shows the geographic impact of Stefan Blech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Blech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Blech more than expected).
Fields of papers citing papers by Stefan Blech
This network shows the impact of papers produced by Stefan Blech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Blech. The network helps show where Stefan Blech may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefan Blech, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humans Hit paper breakdown → | 2007 | 578 |
| 2 | 2010 | 169 | |
| 3 | 2022 | 24 | |
| 4 | 2016 | 19 | |
| 5 | 2012 | 14 | |
| 6 | 2021 | 5 | |
| 7 | 2023 | 5 | |
| 8 | 2024 | 4 |
About Stefan Blech
Stefan Blech is a scholar working on Pharmaceutical Science, Pediatrics, Perinatology and Child Health, Pharmacology, Analytical Chemistry and Environmental Chemistry, having authored 8 papers that have together received 818 indexed citations. Recurring topics across this work include Chemical Reactions and Isotopes (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Pharmaceutical studies and practices (2 papers), Diet and metabolism studies (1 paper), Mass Spectrometry Techniques and Applications (1 paper), Bipolar Disorder and Treatment (1 paper), Protein purification and stability (1 paper) and Atrial Fibrillation Management and Outcomes (1 paper). The work is most often cited by research in Internal Medicine (248 citations), Cardiology and Cardiovascular Medicine (419 citations), Endocrinology, Diabetes and Metabolism (160 citations), Pharmacology (82 citations) and Hematology (59 citations). Stefan Blech has collaborated with scholars based in Germany, United Kingdom and Belgium. Frequent co-authors include Eva Ludwig-Schwellinger, Joachim Stangier, Thomas Ebner, Willy Roth, Klaus F. Wagner, Graeme C. Young, Hanno Schieferstein, John Smeraglia, Inga Bjørnsdottir and Philip Timmerman. Their work appears in journals such as Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, Frontiers in Molecular Biosciences, Bioanalysis and International Journal for Ion Mobility Spectrometry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.